Vaccines & Immunity to Microbial Pathogens 

Known pathogens, such as influenza viruses, HIV, TB, and malaria, and the emergence of new pathogens, such as the Zika virus and SARS-CoV-2, continue to represent frequent and significant threats to human health. Novel or improved vaccines and therapeutics are desperately needed across various infectious disease disciplines.

CVIMP targets all different stages of vaccine development that range from basic vaccine platform development, pivotal animal studies, detailed laboratory-based analysis of immune responses and correlates of protection, GMP production facilities, administrative infrastructure for IND filing, and a clinical trials group that can design and run phase I and II studies.